Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 1998 Jan;74(1):43-53.
doi: 10.1016/S0304-3959(97)00142-5.

Systematic review of factors affecting the ratios of morphine and its major metabolites

Clara C Faura  1 , Sally L Collins, Andrew R Moore, Henry J McQuay
Affiliations
Meta-Analysis

Systematic review of factors affecting the ratios of morphine and its major metabolites

Clara C Faura et al. Pain. 1998 Jan.

Abstract

In a systematic review of 57 studies with information on 1232 patients we examined the effect of age, renal impairment, route of administration, and method of analysis on the ratios of morphine-3-glucuronide:morphine (M3G:M) and morphine-6-glucuronide:morphine (M6G:M) and the relative concentrations of M3G and M6G. Across all studies the range of the ratios of metabolites to morphine was wide (0.001-504 for M3G:M, and 0-97 for M6G:M). Neonates produced morphine glucuronides at a lower rate than older children or adults. Metabolite ratios were higher in renal impairment. Routes of administration which avoided first pass metabolism (intravenous, transdermal, rectal, intramuscular, epidural and intrathecal) resulted in lower metabolite production than oral, buccal or sublingual. Metabolite production was similar for single and multiple dosing. There was no evidence of differences between methods of assay. There was a high correlation between the two glucuronide metabolites in spite of the different situations studied, supporting a single glucuronidating enzyme. Morphine was present in CSF at a fourfold higher concentration than the glucuronide metabolites.

PubMed Disclaimer

References

    1. Aherne WG, Littleton P. Morphine-6-glucuronide, an important factor in interpreting morphine radioimmunoassays. Lancet. 1985;2:210-211.
    1. Ball M, McQuay HJ, Moore RA, Allen MC, Fisher A, Sear J. Renal failure and the use of morphine in intensive care. Lancet. 1985;1:784-786.
    1. Bodd E, Jacobsen D, Lund E, Ripel A, Morland J, Wiik-Larsen E. Morphine-6-glucuronide might mediate the prolonged opioid effect of morphine in acute renal failure. Hum. Exp. Toxicol. 1990;9:317-321.
    1. Bowsher D. Paradoxical pain. Br. Med. J. 1993;306:473-474.
    1. Chauvin M, Sandouk P, Scherrmann JM, Farinotti R, Strumza P, Duvaldestin P. Morphine pharmacokinetics in renal failure. Anesthesiology. 1987;66:327-331.

Publication types